Exact Mass: 1026.5541

Exact Mass Matches: 1026.5541

Found 44 metabolites which its exact mass value is equals to given mass value 1026.5541, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

{[(1R,3S)-3-({[(2R)-2-{[(5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of Leukotriene B4 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0), in particular, consists of one chain of Leukotriene B4 at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

{[(1R,3S)-3-({[(2R)-2-{[(5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0), in particular, consists of one chain of 5(S),15(S)-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

{[(1R,3S)-3-({[(2R)-2-{[(5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxy}-3-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)), in particular, consists of one chain of eicosanoyl at the C-1 position and one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

{[(1R,3S)-3-({[(2R)-3-{[(5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxy}-2-(icosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0), in particular, consists of one chain of 5,6-Dihydroxyeicosatetraenoyl at the C-1 position and one chain of eicosanoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

{[(1R,3S)-3-({[(2R)-2-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-3-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of 11Z-eicosenoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

{[(1R,3S)-3-({[(2R)-3-{[(8Z,11Z,14Z)-5,6-dihydroxyicosa-8,11,14-trienoyl]oxy}-2-[(11Z)-icos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C49H88O18P2 (1026.5446)


PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z)), in particular, consists of one chain of 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of 11Z-eicosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   

caminoside A

caminoside A

C49H86O22 (1026.561)


A glycolipid with an unusual non-glycerol aglycone, 10-hydroxynonadecan-2-one that is glycosylated at the C10 hydroxy group by a branched tetrasaccharide residue. It is isolated from the marine sponge Caminus sphaeroconia and exhibits potent activity as an inhibitor of a type III bacterial secretory system.

   
   
   
   

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

PIP(20:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C49H88O18P2 (1026.5446)


   

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

PIP(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

PIP(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C49H88O18P2 (1026.5446)


   

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

PIP(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

PIP(20:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C49H88O18P2 (1026.5446)


   

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

PIP(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/20:0)

C49H88O18P2 (1026.5446)


   

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

PIP(20:1(11Z)/20:3(8Z,11Z,14Z)-2OH(5,6))

C49H88O18P2 (1026.5446)


   

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

PIP(20:3(8Z,11Z,14Z)-2OH(5,6)/20:1(11Z))

C49H88O18P2 (1026.5446)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z)-tetracosa-9,12,15,18-tetraenoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(7E,9E,11Z,13E,15E,17Z)-icosa-7,9,11,13,15,17-hexaenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (12Z,15Z,18Z)-tetracosa-12,15,18-trienoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[3-[[3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

[3-[[3-[[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoate

C53H88O15P2 (1026.5598)


   

[3-[[3-[[3-[(7E,9E,11E,13E,15Z,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-docosa-13,16-dienoate

[3-[[3-[[3-[(7E,9E,11E,13E,15Z,17E,19E)-docosa-7,9,11,13,15,17,19-heptaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-docosa-13,16-dienoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-3,6,9,12,15,18,21-heptaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (3Z,6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-3,6,9,12,15,18,21-heptaenoate

C53H88O15P2 (1026.5598)


   

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[hydroxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]phosphoryl]oxypropoxy]phosphoryl]oxypropyl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

C53H88O15P2 (1026.5598)


   
   
   

15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4as,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4as,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2z,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2z,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(2z,4e,6e,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2z,4e,6e,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(2e,4e)-15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e)-15-(7-{3-[2-(4-{[4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl)-1,3-oxazol-4-yl]prop-2-en-1-yl}-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl)-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4ar,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

(2r,3r,4s,5r,6s)-6-{[(3r,4r,4ar,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-5-(acetyloxy)-2-methyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}oxan-3-yl (2z)-2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2e,4e,6z,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6z,8e,10s,11s,12r,13r,15r)-15-[(2s,3s,5s,7r,8r,9s)-7-[(2e)-3-{2-[(2r)-4-{[(2r,3r,4r)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

3-(acetyloxy)-2-{[4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

3-(acetyloxy)-2-{[4,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2e,4e,6z,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6z,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

3-(acetyloxy)-2-{[5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

3-(acetyloxy)-2-{[5,10-bis(acetyloxy)-4a,9-bis[(acetyloxy)methyl]-4-hydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-3-yl]oxy}-6-methyl-5-[(2-methylbut-2-enoyl)oxy]oxan-4-yl 2-methylbut-2-enoate

C56H82O17 (1026.5552)


   

(2e,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

(2e,4e,6e,8e,10r,11r,12s,13s,15s)-15-[(2r,3r,5r,7s,8s,9r)-7-[(2e)-3-{2-[(2s)-4-{[(2s,3s,4s)-4-(dimethylamino)-1,2,3-trihydroxy-5-methoxypentylidene]amino}butan-2-yl]-1,3-oxazol-4-yl}prop-2-en-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]decan-2-yl]-11,13-dihydroxy-15-methoxy-3,7,8,10,12-pentamethylpentadeca-2,4,6,8-tetraenimidic acid

C50H83N4O16P (1026.5541)


   

3-(acetyloxy)-6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-[(2-oxononadecan-10-yl)oxy]oxan-3-yl]oxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-4-yl butanoate

3-(acetyloxy)-6-{[4,5-dihydroxy-6-(hydroxymethyl)-2-[(2-oxononadecan-10-yl)oxy]oxan-3-yl]oxy}-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-4-yl butanoate

C49H86O22 (1026.561)